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Gut microbiota plays a critical role in maintaining human intestinal homeostasis and host
health. Bacterial extracellular vesicles are key players in bacteria–host communication,
as they allow delivery of effector molecules into the host cells. Outer membrane vesicles
(OMVs) released by Gram-negative bacteria carry many ligands of pattern recognition
receptors that are key components of innate immunity. NOD1 and NOD2 cytosolic
receptors specifically recognize peptidoglycans present within the bacterial cell wall.
These intracellular immune receptors are essential in host defense against bacterial
infections and in the regulation of inflammatory responses. Recent contributions show
that NODs are also fundamental to maintain intestinal homeostasis and microbiota
balance. Peptidoglycan from non-invasive pathogens is delivered to cytosolic NODs
through OMVs, which are internalized via endocytosis. Whether this pathway could
be used by microbiota to activate NOD receptors remains unexplored. Here, we
report that OMVs isolated from the probiotic Escherichia coli Nissle 1917 and the
commensal ECOR12 activate NOD1 signaling pathways in intestinal epithelial cells.
NOD1 silencing and RIP2 inhibition significantly abolished OMV-mediated activation of
NF-κB and subsequent IL-6 and IL-8 expression. Confocal fluorescence microscopy
analysis confirmed that endocytosed OMVs colocalize with NOD1, trigger the formation
of NOD1 aggregates, and promote NOD1 association with early endosomes. This study
shows for the first time the activation of NOD1-signaling pathways by extracellular
vesicles released by gut microbiota.
Keywords: gut microbiota, Escherichia coli Nissle 1917, NF-κB activation, bacterial extracellular vesicles, NOD1
Abbreviations: DMEM, Dulbecco’s Modified Eagle Medium; DSS, dextran sulfate sodium; DTT, dithiothreitol; EcN,
Escherichia coli Nissle 1917; FBS, fetal bovine serum; LB, Luria-Bertani broth; LPS, lipopolysaccharide; MAMPs, microbial-
associated molecular patterns; NLR, NOD-like receptor; NOD, nucleotide oligomerization domain; OMVs, outer membrane
vesicles; PAGE, polyacrylamide gel electrophoresis; PBS, phosphate buffer saline; PG, peptidoglycan; PRR, pattern
recognition receptor; RIP2, receptor-interacting protein 2; RT-qPCR, quantitative reverse transcription PCR; SDS, sodium
dodecyl sulfate; TLR, Toll-like receptor; ZOs, zonula occludens.
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INTRODUCTION
There is strong scientific evidence that the gut microbiota
has a central role in the well-being of the host. Indeed, this
microbial community is a key orchestrator of the immune system,
contributing to maintenance of tolerogenic immune responses
(Maynard et al., 2012). Communication between microbiota and
intestinal epithelial cells is essential to preserve proper microbiota
balance and intestinal homeostasis. Under healthy conditions,
this inter-kingdom communication is mediated through secreted
bacterial compounds that, unlike whole bacteria, can diffuse
through the intestinal mucus layer and interact with epithelial
cells (Sánchez et al., 2010; Hevia et al., 2015). Besides soluble
proteins, Gram-negative bacteria also release active mediators
into the intestinal lumen through OMVs (Ahmadi-Badi et al.,
2017). Most studies have been focused on pathogen released
OMVs and have proven their role in virulence (Yoon et al., 2011;
Pollak et al., 2012; Bielaszewska et al., 2013; Jäger et al., 2015;
Schwechheimer and Kuehn, 2015; Jung et al., 2016).
In contrast, vesicles released by commensal and probiotic
bacteria have been associated with beneficial effects for the
host. Therefore, it has been suggested that microbiota vesicles
may act as key players to maintain intestinal homeostasis
(Kaparakis-Liaskos and Ferrero, 2015; Patten et al., 2017).
However, there are relatively few reports on this field. Studies
performed with prevalent Gram-negative bacteria that reside in
the human gut showed that OMVs released by Bacteroides fragilis
and Akkermansia muciniphila promote immunomodulatory
effects and prevent gut inflammation in mice models of
experimental colitis (Shen et al., 2012; Kang et al., 2013). In
this context, we have proved that OMVs from the probiotic
EcN and other commensal E. coli strains deliver mediators
that trigger host immune and defense responses. These vesicles
are internalized by intestinal epithelial cells via clathrin-
mediated endocytosis and sorted to lysosomes through endocytic
compartments (Cañas et al., 2016). OMVs from microbiota
E. coli strains exhibit immunomodulatory activity on different
in vitro models of intestinal barrier and in human colonic
explants, regulating expression of antimicrobial peptides and
inflammatory biomarkers toward an anti-inflammatory profile
(Fábrega et al., 2016). Oral administration of OMVs isolated
from the probiotic EcN ameliorate inflammation and colitis
progression in DSS-treated mice, similarly to the administration
of probiotic suspensions (Fábrega et al., 2017). In addition to
immune modulation, EcN OMVs reinforce the intestinal barrier
and reduce gut permeability by promoting upregulation of tight
junction proteins ZO-1 and claudin-14, and downregulation of
claudin-2 (Alvarez et al., 2016).
Despite these early findings that indicate a key role of
bacterial vesicles in signaling processes at the intestinal mucosa,
the specific molecular mechanisms and pathways involved in
microbiota OMVs-host crosstalk remain largely unexplored.
In this regard, vesicles are loaded with MAMPs including LPS,
peptidoglycan, lipoproteins, DNA and RNA, which allow OMVs
to interact directly with host cells via PRRs and activate signaling
pathways that result in cytokine/chemokine modulation
(Kaparakis-Liaskos and Ferrero, 2015; Patten et al., 2017).
Besides recognition of extracellular TLRs, commensal bacteria
can also signal through cytosolic NLRs, which include two
members, NOD1 and NOD2 (Natividad et al., 2012).
NOD1 is constitutively expressed in most cell types and
especially by epithelial cells in the intestinal tract, whereas NOD2
is mainly expressed in immune cells of myeloid origin. However,
low expression of NOD2 has also been reported in intestinal
epithelial cells, where certain stimuli such as pro-inflammatory
cytokines or infection with enteroinvasive pathogens can up-
regulate its expression (Rosenstiel et al., 2003; Kim et al., 2004).
NOD receptors consist of three domains: (i) an N-terminal
caspase-activated recruitment domain (CARD) that allows
protein–protein interactions, (ii) a central NACHT domain
involved in receptor dimerization, and (iii) a C-terminal leucine-
rich repeat (LRR) domain that recognizes specific ligands. Both
NOD1 and NOD2 are activated by intracellular fragments
of bacterial peptidoglycan, thereby acting as intracellular
sensors of bacterial infection. NOD1 detects D-glutamyl-meso-
diaminopimelic acid (iE-DAP) present in Gram-negative PG, but
also in specific groups of Gram-positive bacteria, while NOD2
detects muramyl dipeptide (MDP), which is common to all
groups of bacteria. PG interaction elicits NOD oligomerization,
which in turn promotes the recruitment of the downstream
RIP2, a specific kinase that triggers activation of NF-κB and
mitogen-activated protein kinase (MAPK) pathways leading to
the expression of inflammatory genes. NOD receptors have
essential roles not only in host responses against bacterial
infection, but also in the regulation of intestinal inflammatory
response to microbiota, and thus in maintaining intestinal
homeostasis (reviewed in Caruso et al., 2014; Philpott et al., 2014;
Kaparakis-Liaskos, 2015).
In addition to PG entry through cell infection by invasive
bacteria, other intracellular PG delivery pathways have been
described in non-invasive bacteria. These alternative routes
include PG translocation through bacterial secretion systems,
uptake by endocytosis or by specific membrane transport systems
(PEPT), and delivery via OMVs (reviewed in Philpott et al.,
2014; Kaparakis-Liaskos, 2015). Delivery of PG inside the host
cell and further activation of NOD signaling cascades by
bacterial OMVs have been studied in pathogens, specifically
Helicobacter pylori (Kaparakis-Liaskos et al., 2010), Vibrio
cholerae (Chatterjee and Chaudhuri, 2013), and Aggregatibacter
actinomycetemcomitans (Thay et al., 2014). OMVs from these
pathogens induce an inflammatory response that is NOD1-
dependent. Studies performed with H. pylori OMVs revealed
that delivery of endocytosed PG-containing OMVs to cytosolic
NOD1 is triggered by recruitment of the cytosolic receptor to
early endosomes. This intracellular trafficking was shown to be
essential for NOD1-PG interaction and activation of the signaling
cascade that leads to nuclear NF-κB translocation (Irving et al.,
2014).
Intracellular PG delivery by means of bacterial extracellular
vesicles points to a plausible mechanism used by microbiota
to activate NOD-mediated host immune responses. The aim
of the present study was to evaluate whether OMVs from
probiotic and commensal E. coli could activate NOD signaling
pathways in intestinal epithelial cells. Here, we show that
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in Caco-2 cells NOD1, but not NOD2, is essential for the
immune responses mediated by EcN or ECOR12 OMVs. OMV-
mediated activation of NF-κB and the subsequent IL-6 and IL-8
responses are significantly reduced by NOD1 silencing or RIP2
inhibition. Colocalization of endocytosed OMVs with NOD1 was
confirmed by confocal fluorescence microscopy. This analysis
also provides evidence of NOD aggregation and association with
early endosomes in cells stimulated with EcN or ECOR12 OMVs.
MATERIALS AND METHODS
Bacterial Strains and Growth Conditions
The probiotic EcN (serotype O6:K5:H1) was provided by
Ardeypharm GmbH, Herdecke, Germany. ECOR12 (O7:H32)
is a strain of the E. coli reference collection that was isolated
from the stool of a healthy human (Ochman and Selander, 1984).
Bacterial cells were routinely grown at 37◦C in LB with constant
rotation (150 rpm). Growth was monitored by measuring the
optical density at 600 nm.
Isolation and Labeling of OMVs
OMVs were isolated from culture supernatants as described
previously (Aguilera et al., 2014). Briefly, bacterial strains
were grown aerobically in LB and collected by centrifugation
at 10,000 × g for 20 min at 4◦C. The supernatants were
filtered through a 0.22 µm-pore-size filter (Merck Millipore)
to remove remaining bacteria and concentrated using a 10k
Centricon R© Plus-70 filter unit (Merck Millipore). Vesicles
were pelleted by centrifugation at 150,000 × g for 1 h
at 4◦C in an OptimaTM L-90K ultracentrifuge (Beckman
Coulter), washed twice, resuspended in PBS and stored at
−20◦C. Sterility of samples was assessed on LB plates. Protein
concentration was measured by the method of Lowry et al.
(1951). The reproducibility of OMV preparations was assessed
by transmission electron microscopy after negative staining and
SDS-PAGE as described previously (Aguilera et al., 2014).
Outer membrane vesicles were fluorescently labeled with
BODIPYFL vancomycin (Thermo Fisher Scientific), which
selectively reacts with PG. To this end, EcN and ECOR12 OMVs
(2 mg/ml) were incubated for 1 h at room temperature in the
presence of 4 ng/ml of BODIP R©YFL vancomycin. Unbound dye
was removed by washing two times in PBS. Labeled OMVs were
then collected by centrifugation at 100,000× g for 1 h at 4◦C.
Cell Culture and Stimulation Conditions
The human colonic cells lines Caco-2 (ATCC HTB37) and
HT-29 (ATCC HTB-38) were from the American Type
Culture Collection. Previous studies of our group showed
that EcN and ECOR12 OMVs are internalized by both
intestinal epithelial cells through clathrin-mediated endocytosis,
ruling out cell-dependent differences in the endocytic and
intracellular trafficking pathways (Cañas et al., 2016).
Epithelial cells were cultured in DMEM High Glucose (Life
Technologies) supplemented with 10% (v/v) fetal bovine
serum (FBS), 25 mM HEPES, 1% non-essential amino
acids, penicillin (100 U/ml) and streptomycin (100 µg/ml)
(Gibco BRL, Gaithersburg, MD, United States). Cultures were
incubated at 37◦C in a 5% CO2 atmosphere. Cells were routinely
sub-cultured once a week with trypsin-EDTA (0.25%, 0.53 mM)
and seeded at a density of 2× 105 cell/ml.
For gene silencing, Caco-2 intestinal epithelial cells (2 × 105
cell/ml) were seeded in 12 well tissue culture plates and
grown until 70–80% of confluence. Then, medium was replaced
with antibiotic-free medium, and cells were transfected with
specific NOD1 (Santa Cruz Biotechnology sc-37279) or NOD2
(Santa Cruz Biotechnology sc-43973) small interfering RNA
(siRNA) following the manufacturer’s instructions. A negative
control siRNA (Santa Cruz Biotechnology sc-37007) was used
as reference. The transfection and medium reagent used in this
study were also obtained from Santa Cruz Biotechnology. After
48 h, the culture medium was replaced with fresh DMEM and
NOD1 and NOD2 knockdown Caco-2 cells were stimulated with
EcN or ECOR12 OMVs, at dose of 10 µg/ml, for 8 h. To inhibit
RIP2, Caco-2 cells were treated with 1 µM of RIP2 tyrosine
kinase inhibitor Gefitinib (Invivogen) for 1 h prior the addition
of OMVs (10 µg/ml), and then incubated in the presence of
the inhibitor for an additional 8 h. As a positive control Caco-2
cells (control, NOD1 silenced, and Gefitinib treated cells), were
stimulated for 8 h with 1 µg/ml of M-TRiDAP (MurNAc-L-Ala-
gamma-D-Glu-mDAP) (Invivogen), a PG degradation product
found mostly in Gram-negative bacteria that is recognized by
the intracellular receptor NOD1. In all cases, supernatant and
cells were collected for ELISA and quantitative RT-PCR assays,
respectively.
Analysis of NF-κB Activation in Caco-2
Cells
To measure activation of the nuclear transcription factor NF-κB,
control Caco-2 cells as well as cells treated with the RIP-2
inhibitor or transfected with NOD1 siRNA were stimulated
with 10 µg/ml of EcN and ECOR12 OMVs at different timings
(20, 40, 90, 120, 150, and 180 min). Then, cells were washed
with 1X PBS and suspended in lysis buffer (50 mM Tris-HCl
(pH 8.0), 170 mM NaCl, 0.5% NP4O, 50 mM NaF, 25% glycerol,
10 mg/ml proteinase A, 10 mg/ml leupeptine, 1 mM DMSF,
0.1 mM Na3, 20 mM β-glycerolphosphate, and 1 mM DTT) for
1 h at 4◦C. Cell lysate was clarified by centrifugation at 16,000× g
for 30 min at 4◦C. Protein concentration was measured by
the Bradford Protein Assay (Bio-Rad). NF-κB activation was
evaluated through IkBα degradation by Western blot. Samples
(100 µg protein) were mixed with SDS-PAGE sample loading
buffer, boiled for 5 min at 95◦C and electrophoresed on
10% SDS-PAGE gel. Proteins were transferred to a Hybond-
P polyvinylidene difluoride membrane using a Bio-Rad Mini
Transblot apparatus. The membrane was blocked in PBS-0.05%
Tween-20 and 5% skimmed milk (blocking solution) for 1 h
at room temperature, and incubated with specific antibodies
against IκBα (Santa Cruz Biotechnology), 1:500 dilution in
blocking solution overnight at 4◦C, followed by incubation with
peroxidase-conjugated anti-mouse IgG antibody (1:7000) for
1 h at room temperature. The antibody-protein complex was
visualized using the ECL Plus Western blotting detection system
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(GeHealthcare). Detection of the housekeeping NEK9 protein
was used as an internal loading and transfer control.
Confocal Fluorescence Microscopy
HT-29 cells were grown in 8-well chamber slider (Ibidi) until
approximately 80% confluence and incubated with EcN and
ECOR12 OMVs (10 µg/well) at 37◦C. When indicated cells were
incubated with BODIPYL-FL labeled OMVs. After stimulation,
cells were washed three times in PBS. Nuclei were labeled
with DAPI (0.125 µg/ml, Sigma-Aldrich). Then, samples were
fixed with 3% paraformaldehyde for 30 min, permeabilized
with 0.05% saponin (Sigma-Aldrich) and blocked with PBS
containing 1% bovine serum albumin for microscopy analysis.
Unlabeled OMVs were visualized using anti-E. coli LPS mouse
monoclonal antibody (Abcam R©) followed by Alexa Fluor 488
conjugated goat anti-mouse IgG (Molecular Probes). NOD1
receptor was detected using anti-NOD1 policlonal antibody
(Thermofisher) and Alexa Fluor 633 conjugated goat anti-rabbit
IgG (Molecular Probes). Endosomes were labeled with mouse
polyclonal antibody against EEA1 (Santa Cruz Biotechnology)
and Alexa Fluor 488-conjugated goat anti-rabbit IgG (Molecular
Probes).
Immunofluorescence labeling of cells was analyzed
by confocal microscopy using a Leica TCS SP2 laser
scanning confocal spectral microscope with a 63x 1.32NA
oil immersion objective and an image resolution of
0.232 × 0.232 × 0.488 µm/voxel (x, y, z, respectively).
Images were captured with a Nikon color camera (8 bit).
Fluorescence was recorded at 405 nm (blue; DAPI), 488 nm
(green; BODIPYL-FL, Alexa Fluor 488), 546 nm (red; WGA),
and 633 nm (far-red; Alexa Fluor 633). Images were analyzed
using Fiji image processing package (Schindelin et al., 2012).
Colocalization was analyzed by calculating the overlap coefficient
(r), which values range from 0 to 1. For the calculation, data
were obtained from four confocal stacks (x-y) using the JaCoP
plugin. The total number of cells analyzed was between 60 and
70. Data were presented as mean ± standard error (SEM) from
three independent biological experiments.
Cytokine Quantification
After stimulation, culture supernatants were collected and
centrifuged at 16,000 × g for 20 min at 4◦C, and stored
at −80◦C until assay. IL-8 and IL-6 secreted levels were
quantified by enzyme-linked immunosorbent assay (ELISA) sets
(BD Biosciences) according to manufacturer’s instructions. The
results were expressed as pg/ml.
RNA Isolation and Quantitative Reverse
Transcription PCR (RT-qPCR)
Total RNA was isolated from Caco-2 cells using the Illustra
RNAspin Mini kit (GE Healthcare) according to the
manufacturer’s protocol. Purity and RNA concentration
were assessed by the absorbance ratio at 260 and 280 nm
in a NanoDrop R© spectrophotometer. RNA integrity was
evaluated by visualization of 28S and 18S rRNAs after 1%
agarose/formaldehyde gel electrophoresis.
RNA (1 µg) was reverse transcribed using the High Capacity
cDNA Reverse Transcription kit (Applied Biosystems) in a
final volume of 20 µl. RT-qPCR reactions were performed
in a StepOne Plus PCR cycler (Applied Biosystems) by using
SYBR Green PCR Master Mix (Applied Biosystems) and specific
primers for human IL-6, IL-8, NOD-1, and NOD-2 (Table 1).
A control reaction was performed in the absence of RNA. The
2−11Ct method was used to normalize expression results. The
expression level of the housekeeping β-actin gene was used as a
reference to normalize the expression values of the genes under
study.
Statistical Analyses
Statistical analysis was performed using SPSS (version 20.0,
Chicago, IL, United States) software package. Results are
presented as the mean ± standard error (SEM) of three
independent biological experiments, assayed in triplicate.
Differences between two groups were assessed using one-way
ANOVA followed by Tukey’s test. The p-value < 0.05 was
considered statistically significant.
RESULTS
EcN and ECOR12 OMVs Activate the
Innate Inflammatory Response in an
NOD1 Dependent Manner in Intestinal
Epithelial Cells
In non-invasive pathogens, internalized OMVs allow
intracellular delivery of PG to activate NOD receptors upon their
recruitment to early endosomes (Irving et al., 2014). Whether
microbiota could activate these intracellular receptors through
extracellular vesicles remains unknown. Thus, we sought to
analyze whether OMVs released by the commensal ECOR12 and
the probiotic EcN can trigger the NOD inflammatory response
in intestinal epithelial cells.
First, we analyzed by RT-qPCR the expression of NOD1 and
NOD2 in two intestinal epithelial cells lines, HT-29 and Caco-2.
Both intracellular receptors were constitutively expressed in the
two cell lines, but their relative expression level was higher
in Caco-2 cells (Figure 1A). It must be stressed that NOD2
TABLE 1 | Primer sequences used for RT-qPCR.
Gene Primer sequence Reference
NOD1 5′-ACGATGAAGTGGCAGAGAGTT-3′ Boonyanugomol et al., 2013
5′-GGCAGTCCCCTTAGCTGTGA-3′
NOD2 5′-GAAGTACATCCGCACCGAG-3′ Sabbah et al., 2009
5′-GACACCATCCATGAGAAGACAG-3′
IL-8 5′-CTGATTTCTGCAGCTCTGTG-3′ Martirosyan et al., 2013
5′-GGGTGGAAAGGTTTGGAGTATG-3′




Takahashi et al., 2011
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FIGURE 1 | Expression analysis of NOD1 and NOD2 in intestinal epithelial
cells. Relative mRNA levels of NOD1 and NOD2 were measured by RT-qPCR,
using β-actin as the reference gene. (A) Relative mRNA levels of NOD1 and
NOD2 in HT-29 and Caco-2 cells. Data correspond to the mean ± SEM of
three independent biological experiments and are presented as relative
expression in Caco-2 cells in comparison with mRNA levels in HT-29, which
were set at 1 (∗p < 0.010). (B) Relative mRNA levels of NOD1 and NOD2 in
Caco-2 cells after 8 h-stimulation with OMVs isolated from EcN or ECOR12.
Data correspond to the mean ± SEM of three independent biological
experiments and are presented as fold-change compared to untreated control
cells, whose normalized values were set as 1 and indicated by a dashed line
(∗p ≤ 0.05).
expression was very low. The threshold cycle (Ct) values for
NOD2 detection were around 10 times higher than those for
NOD1. These results are in accordance with the expression
profile reported for these receptors in several epithelial cell lines
evaluated by semi-quantitative RT-PCR (Kim et al., 2004).
To approach functional studies, we selected Caco-2 cells
as they express higher levels of intracellular NOD receptors
than HT-29. In addition, we took advantage of the negligible
expression of TLR4 and its co-receptor MD-2 in this cell line
(Abreu et al., 2001; Kim et al., 2004). This avoids interference
by the other main inflammatory pathways activated by vesicle
components other than PG, such as LPS. NOD1 is constitutively
expressed in intestinal epithelial cells, while NOD2 is upregulated
by treatment with specific pro-inflammatory cytokines or
by infection with invasive bacteria. To test whether NOD2
expression could be upregulated in intestinal epithelial cells
by internalized OMVs from microbiota strains, the relative
expression of both NOD receptors was assessed in Caco-2 cells
challenged with EcN or ECOR12 OMVs (10 µg/ml). The basal
NOD1 and NOD2 mRNA levels remained unchanged after 8 h
stimulation (Figure 1B).
To analyze whether internalized OMVs elicit an inflammatory
response through activation of NOD1 and/or NOD2 receptors,
we examined OMV-induced responses in Caco-2 cells silenced
for NOD1 or NOD2 expression. To this end, Caco-2 cells were
transfected with siRNA specific sequences targeting these NOD
receptors, or with control scrambled siRNA (Scr). After 2 days,
knockdown of NOD1 or NOD2 gene expression in these cells
was assessed by qRT-PCR. The levels of NOD1 and NOD2
mRNA were significantly decreased by 50 and 55%, respectively,
compared with scrambled transfected cells (Supplementary
Figure S1). Then, transfected cells were stimulated for 8 h with
OMVs from EcN or ECOR12, and the expression of IL-8 and
IL-6 was quantified by RT-qPCR. Both bacterial vesicles induced
significant levels of IL-6 and IL-8 mRNA expression in control
cells (transfected with Scr siRNA).
NOD2 silencing did not impair OMV-mediated upregulation
of either IL-6 or IL-8, as both mRNA and cytokine secreted
levels remained similar to those of control Scr-transfected cells
(Figure 2). In contrast, NOD1 siRNA-transfected cells displayed
significantly reduced mRNA levels of IL-6 (sevenfold decrease)
and IL-8 (twofold decrease) in response to OMV stimulation
(Figure 3A). In NOD1-knockdown cells the observed changes in
cytokine mRNA expression correlated with the secreted protein
levels quantified by ELISA (Figure 3B). In response to OMVs,
secreted IL-6 and IL-8 levels were lower in NOD1-silenced cells
than in Scr-control cells; although for IL-8 the results did not
reach statistical significance (Figure 3B). Stimulations with Tri-
DAP, a cognate activator of the NOD1 signaling pathway, were
performed in parallel to assess functional NOD1 activity in these
cells. Consistently, IL-6 and IL-8 expression was significantly
reduced by NOD1-specific siRNA treatment at both mRNA and
protein levels (Figures 3A,B). Overall, these results indicate
that NOD1, but not NOD2, is involved in the IL-6 and IL-8
responses triggered by internalized EcN or ECOR12 OMVs in
intestinal epithelial cells, although NOD1-independent pathways
also contribute to IL-8 production.
As RIP2 specifically mediates pro-inflammatory signaling
from NOD1 bacterial sensors (Park et al., 2007), we next sought
to analyze IL-6 and IL-8 production in response to microbiota
OMVs in Caco-2 cells treated with the RIP2 inhibitor Gefitinib.
To this end, cells were pre-treated with Gefitinib (1 µM) prior
to the addition of EcN or ECOR12 OMVs, and the levels of
IL-6 and IL-8 were measured after 8 h-incubation. Inhibition
of RIP2 significantly reduced the expression and secretion of
both pro-inflammatory cytokines in response to OMVs in Caco-
2 cells compared to OMV-stimulated controls (Figures 3C,D).
These findings support the requirement of the RIP2 kinase in
the inflammatory response to internalized microbiota OMVs,
and therefore confirm the ability of microbiota OMVs to
activate intracellular NOD1 and the downstream signaling
pathway.
EcN and ECOR12 OMVs Activate NF-κB
Through the NOD1-RIP2 Pathway
Activation of RIP2 results in the phosphorylation and subsequent
degradation of IκBα, which in turn allows activation and
translocation of the NF-κB complex into the nucleus, where
it induces the transcription of target pro-inflammatory genes
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FIGURE 2 | NOD2 is not essential for the OMV-mediated activation of IL-6 and IL-8 expression in Caco-2 cells. Caco-2 cells were transfected with siRNA against
NOD2 or with control scrambled siRNA (Scr) as a control. After 48 h, cells were stimulated with OMVs (10 µg/ml) isolated from EcN or ECOR12 strains or left
non-stimulated. (A) Relative mRNA levels of the pro-inflammatory cytokines IL-6 and IL-8 were measured after 8 h by RT-qPCR, using β-actin as the reference gene.
Data are expressed as fold-change compared to non-stimulated Scr-control cells. (B) Secreted IL-6 and IL-8 were quantified by ELISA at 8 h post-stimulation. In all
panels, data correspond to the mean ± SEM of three independent biological experiments.
(Chin et al., 2002). To confirm activation of NF-κB in cells
challenged with OMVs, levels of IκBα were assessed by Western
blot at different post-treatment times. Stimulation of Caco-2
cells with EcN or ECOR12 OMVs caused significant degradation
of IκBα. The time kinetics of IκBα degradation was somewhat
slower for ECOR12 OMVs (Figure 4A). Degradation of IκBα
was not observed when cells were either transfected with
NOD1 siRNA or treated with the RIP2 inhibitor Gefitinib
(Figures 4B,C). In NOD2-silenced cells, OMV-mediated IκBα
degradation followed the same pattern as control Caco-2 cells
(Figure 4D). These data confirm that OMVs released by E. coli
microbiota strains activate the NF-κB pathway in an NOD1-
dependent manner.
EcN and ECOR12 OMVs Associate With
NOD1 and Trigger Its Aggregation
NOD1 detection of PG contained in Gram-negative derived
OMVs is required for activation of the downstream signaling
pathway. Thus, association of NOD1 with OMVs from EcN
and ECOR12 was evaluated by means of confocal fluorescence
microscopy. OMVs were visualized by immunostaining
with anti-E. coli LPS and Alexa Fluor 546-conjugated anti-
mouse IgG antibodies. After 1 h post-stimulation, OMVs
from both strains colocalized with NOD1 in HT-29 cells
(Figure 5). The degree of colocalization was assessed from
the corresponding overlap coefficients (r), with values of
0.51 ± 0.03 for EcN and 0.48 ± 0.01 for ECOR12 vesicles.
Colocalization of internalized vesicles with NOD1 was confirmed
in HT-29 cells incubated with EcN OMVs fluorescently
labeled with BODIP R©YFL vancomycin (Supplementary
Figure S2).
It is well-known that direct binding of PG ligand to NOD1
triggers self-association of the receptor via the NACHT domain.
This is a key step for the recruitment of RIP2 to initiate the
phosphorylation cascade that results in the assembly of large
signaling complexes (Philpott et al., 2014). To address whether
microbiota OMVs induce changes in the NOD1 oligomerization
state, confocal fluorescence microscopy of NOD1 was performed
in HT-29 at different post-incubation times (20, 60, 90, and
180 min). Non-stimulated cells were processed in parallel as a
control. These analyses revealed that upon OMVs stimulation,
NOD1 formed aggregates in the cell cytoplasm in a time-
dependent manner, which may arise by oligomerization upon
NOD1 activation (Figure 6). Remarkably, NOD1 activation
timing profiles differed between OMVs. The pattern of NOD1
aggregation was already apparent at 20 min post-stimulation
with EcN OMVs, and gradually increased up to 180 min.
However, changes in the NOD1 fluorescence signal pattern were
delayed in cells treated with ECOR12 OMVs. At 180 min,
both OMVs elicited a similar NOD1 aggregation level. These
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FIGURE 3 | EcN and ECOR12 OMVs activate IL-6 and IL-8 expression in intestinal epithelial cells in a NOD1- and RIP2-dependent manner. Caco-2 cells were
stimulated for 8 h with OMVs (10 µg/ml) isolated from EcN or ECOR12 strains or with M-TriDAP (1 µg/ml) as a positive control of NOD1 activation. Control cells were
left unstimulated for comparison. (A,B) Involvement of NOD1 in the OMV-mediated activation of IL-6 and IL-8 responses was assessed in NOD1-silenced cells. Two
days before the stimulation with OMVs or with M-TriDAP, Caco-2 cells were transfected with siRNA against NOD1 or with control scrambled siRNA (Scr). Expression
of these cytokines was quantified after 8 h incubation: (A) relative mRNA levels of IL-6 and IL-8 were measured by RT-qPCR using β-actin as the reference gene, and
(B) secreted IL-6 and IL-8 were quantified by ELISA. (C,D) Requirement of RIP2 in the OMV-mediated activation of IL-6 and IL-8 responses was assessed in Caco-2
cells treated with the RIP2 inhibitor Gefitinib. Prior to the addition of OMVs or M-TriDAP, cells were pre-treated with Gefitinib (1 µM) for 1 h. Expression of IL-6 and
IL-8 was quantified by (C) RT-qPCR and (D) ELISA as described for NOD1-knockdown cells. In all panels data are presented as mean ± SEM of three independent
biological experiments (∗p ≤ 0.05 versus non-stimulated controls). Relative mRNA levels (A,C) are expressed as fold-change compared to non-stimulated controls.
results are consistent with the different IκBα degradation profile
observed in Caco-2 cells in response to these E. coli derived
OMVs.
NOD1 Is Recruited to Early Endosomes
by EcN and ECOR12 OMVs
It has been described that NOD1 detection of OMV-internalized
PG takes place at early endosomes (Irving et al., 2014).
In this context, we have previously shown that EcN and
ECOR12 OMVs are sorted to early endosomes during their
intracellular trafficking through clathrin-mediated endocytosis
(Cañas et al., 2016). To assess whether NOD1 could be
recruited to early endosomes by internalized microbiota OMVs,
colocalization of NOD1 with the endosome-associated EEA1
protein was analyzed by confocal fluorescence microscopy in
HT-29 cells at 1 h post-stimulation. Non-treated control cells
were analyzed in parallel for comparison. Colocalization of
NOD1 with the specific endosome marker was only observed
in OMVs stimulated cells (Figure 7). No yellow spots were
apparent in the merged images collected from control cells.
In stimulated cells, the presence of OMVs in early endosomes
was confirmed by their colocalization with EEA1 (not shown).
Quantitative analysis revealed similar overlapping coefficient
values for colocalizations of EEA1/NOD1 (r = 0.38 ± 0.03
in EcN OMV-treated cells and r = 0.34 ± 0.01 in ECOR12
OMV-treated cells) and EEA1/LPS-OMVs (r = 0.44 ± 0.08
for EcN OMVs and r = 0.39 ± 0.04 for ECOR12 OMVs).
These results indicate that NOD1 detection of PG internalized
via microbiota OMVs also depends on its recruitment to early
endosomes.
DISCUSSION
It is well-known that intestinal microbiota releases many
regulatory signals that modulate the development and
function of the intestinal immune system. To house this
huge microbial population, the intestinal tract needs barrier
and regulatory mechanisms to control reciprocal interactions
between microbiota, the epithelium and the mucosal immune
system, preventing aberrant responses and maintaining
homeostasis. In the gut, host–microbiota crosstalk mainly
depends on secreted factors that can diffuse across the
mucus layer and gain access to the epithelium. Among
bacterial secreted factors, bacterial extracellular vesicles
have relevant role in bacteria–host communication, as they
allow the intracellular delivery of bacterial effector upon
internalization into the host cells. OMVs released by Gram-
negative bacteria enclose many ligands recognized by PRRs
such as LPS (TLR4 ligand), PG (NOD1/NOD2 ligand), or DNA
(TLR9 ligand). These receptors, expressed by epithelial and
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FIGURE 4 | Inhibition of RIP2 impairs OMVs-induced NF-κB activation in Caco-2 cells. Activation of NF-κB was assayed by means of IκBα degradation. (A) Caco-2
cells were stimulated with EcN or ECOR12 OMVs (10 µg/ml) for 20, 40, 90, 120, 150 and 180 min, and IκBα levels were assessed by Western blot. For
normalization, blots were probed with an anti-NEK-9 antibody. For comparison, parallel stimulations were performed in Caco-2 cells treated with the RIP2 inhibitor
Genfitinib (1 µM) (B), transfected with si-NOD1 (C), or transfected with si-NOD2 (D). Densitometric quantification of IκBα was performed with samples from three
independent experiments. Representative immunoblots were shown. Normalized values from untreated control cells (time 0 min) were set as 1. Significance against
untreated control cells (∗p ≤ 0.05).
FIGURE 5 | NOD1 colocalizes with EcN and ECOR12 OMVs. HT-29 cells were incubated with EcN or ECOR12 OMVs (10 µg) for 1 h and analyzed using laser
scanning confocal spectral microscope. NOD1 was stained using anti-NOD1 polyclonal antibody and Alexa Fluor 633-conjugated goat anti-rabbit IgG (red). OMVs
were stained using anti-Escherichia coli LPS mouse monoclonal antibody followed by Alexa Fluor 488-conjugated goat anti-mouse IgG (green). Images are
representative of three independent biological experiments. Colocalization of the red and green signals was confirmed by histogram analysis of the fluorescence
intensities along the yellow lines. Analysis was performed by laser scanning confocal spectral microscope with 63x oil immersion objective lens, and images were
captured with a Nikon color camera (8 bit). Scale bar: 10 µm.
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FIGURE 6 | Time-course analysis of NOD1 aggregation pattern in HT-29 cells in response to EcN or ECOR12 OMVs. HT-29 cells were incubated with EcN or
ECOR12 OMVs (10 µg) for the indicated times and analyzed using laser scanning confocal spectral microscope. NOD1 was stained using anti-NOD1 polyclonal
antibody and Alexa Fluor 633-conjugated goat anti-rabbit IgG. Images are representative of three independent biological experiments and are presented in
color-code Fire. Analysis was performed as described for Figure 5. Scale bar: 10 µm.
immune cells, are crucial components of innate immunity
as they detect gut microbes and elicit suitable immune
responses.
NOD1 and NOD2 cytosolic receptors detect PG, a component
of the cell wall of Gram-negative and Gram-positive bacteria
(Girardin et al., 2003). Many studies have shown the pivotal
role of these immune receptors in defense against bacterial
infections and in the modulation of host inflammatory responses
(Caruso et al., 2014; Philpott et al., 2014). In addition
to this function as sensors of bacterial pathogens, recent
contributions evidenced that NODs are also fundamental
to maintain intestinal homeostasis and microbiota balance
(Rehman et al., 2011; Philpott et al., 2014). In fact, mutations
that affect NOD2 expression or activity have been associated
with multiple chronic inflammatory and autoimmune diseases
(Feerick and McKernan, 2016). In this context, boosting the
stimulation of NOD receptors by microbiota has been proposed
as a mechanism to ensure gut homeostasis by enhancing
innate immunity (Clarke et al., 2010). Nevertheless, how
gut microbiota, which is composed of non-invasive bacteria,
can deliver PG into host cells is a rather unexplored issue.
A plausible pathway is that PG fragments released into the
intestinal lumen during bacterial cell division are internalized
by epithelial cells through endocytosis or by oligopeptide
transporters such as PEPT1 or PEPT2 (Swaan et al., 2008;
Philpott et al., 2014). NOD-activating PG products have been
found in E. coli culture supernatants (Pradipta et al., 2010),
and PG fragments released by L. salivarius protect colitis
progression in mice by upregulating IL-10 (Macho-Fernández
et al., 2011).
Another pathway for intracellular PG delivery is through
bacterial vesicles. This a well-studied mechanism in Gram-
negative pathogens such as H. pylori, V. cholerae, and
A. actinomycetemcomitans (Kaparakis-Liaskos et al., 2010; Bielig
et al., 2011; Thay et al., 2014). Studies performed with
H. pylori revealed that internalized OMVs reach endosomal
compartments, and that interaction with OMV-PG takes place
at early endosomes (Irving et al., 2014). With this information,
we hypothesized that microbiota-released OMVs could mediate
immunomodulatory effects through NOD activation by their
PG. Previous contributions of our group showed that OMVs
from commensal and probiotic E. coli strains enter the intestinal
epithelial cells via clathrin-dependent endocytosis (Cañas et al.,
2016) and elicit immunomodulatory and barrier reinforcement
responses (Alvarez et al., 2016; Fábrega et al., 2016). Several
vesicle cargo molecules and MAMPs can account for these effects,
thus involving a number of immune receptors and signaling
pathways. To evaluate involvement of the NOD signaling
pathways in the immune response triggered by commensal E. coli
strains we used the epithelial cell line Caco-2, which poorly
responds to LPS due to low expression of TLR4 and their co-
receptor MD-2 (Abreu et al., 2001; Kim et al., 2004).
Our results show that OMVs from the commensal ECOR12
and the probiotic EcN induce an innate immune response in
Caco-2 cells by activating NOD1-signaling cascades, which led to
activation of NF-κB and secretion of pro-inflammatory cytokines
IL-6 and IL-8. Several factors led us to rule out the involvement
of NOD2 in these responses: (i) intestinal epithelial cells express
very low levels of NOD2, (ii) NOD2 expression is not upregulated
by microbiota E. coli OMVs, and (iii) NOD2 silencing did not
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FIGURE 7 | NOD1 colocalizes with EEA1-labeled endosomes in cells stimulated with EcN or ECOR 12 OMVs. HT-29 cells were incubated with EcN or ECOR12
OMVs (10 µg) for 1 h and colocalization of EEA1/NOD1 was analyzed using laser scanning confocal spectral microscope. NOD1 was stained using anti-NOD1
polyclonal antibody and Alexa Fluor 633-conjugated goat anti-rabbit IgG (red). Endosomes were detected with mouse polyclonal antibody against EEA1 and Alexa
Fluor 488-conjugated goat anti-rabbit IgG (green). Images are representative of three independent biological experiments. Colocalization of the red and green signals
was confirmed by histogram analysis of the fluorescence intensities along the yellow lines. Analysis was performed as described for Figure 5. Scale bar: 10 µm.
affect OMV-activated IL-6 and IL-8 responses. In contrast, NOD1
silencing and RIP2 inhibition significantly decreased expression
of these pro-inflammatory cytokines at both mRNA and protein
levels. Interestingly, EcN and ECOR12 OMVs elicited greater
activation of IL-8 than the specific NOD1 ligand Tri-DAP (used
at 1 µg/ml), thus indicating the relative contribution of MAMPs
other than PG to OMV-mediated activation of IL-8 secretion.
Activation by OMVs of other signaling pathways that lead to
IL-8 expression may explain why IL-8 secreted levels were not
significantly reduced by treatments that interfere with NOD1
levels (NOD1-kockdown cells) or RIP2 activity (Gefitinib-treated
cells).
In cells stimulated with EcN or ECOR12 OMVs, NOD1-
mediated activation of NF-κB was confirmed by measuring IκBα
degradation. As expected, both OMVs triggered degradation of
this IκB inhibitory protein, and the effect was not observed
in RIP2 inhibited cells. Interestingly, both OMVs triggered
IκBα degradation with different kinetics, which were faster for
EcN OMVs. In cells treated with vesicles from the probiotic
EcN, a reduction in IκBα levels was apparent at 40 min post-
stimulation, with values that were statistically significant at
90 min and later times. However, vesicles from the commensal
ECOR12 did not cause any significant changes in IκBα levels
until 120 min. At 120 min, IκBα levels were reduced by more
than 60% in cells treated with EcN OMVs, but by around
40% in cells treated with ECOR12 OMVs. At 180 min, no
differences in IκBα levels were observed between EcN- or
ECOR12-treated cells. The different IκBα degradation timing
profile was compatible with the kinetics of NOD1 aggregation in
OMVs-treated cells. NOD1 aggregation may be used as a sign
of NOD1 activation that leads to NOD1 oligomerization and
recruitment of other proteins to form large signaling complexes
(Sorbara et al., 2013; Irving et al., 2014). Analysis by confocal
fluorescence microscopy evidenced that the kinetics of NOD1
aggregation in response to internalized ECOR12 OMVs was
slower than that triggered by EcN OMVs. Up to 90 min, the
smaller number of NOD1 activated complexes observed in the
cytosol of ECOR12-treated cells correlated well with the lower
IκBα degradation ratios estimated by Western blot at the same
incubation times.
The intracellular compartment where the PG contained in
OMVs internalized via clathrin-mediated endocytosis interacts
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with cytosolic NOD1 was elucidated through an elegant study
performed with H. pylori OMVs. Results from this study
revealed that such interaction takes place at the membrane of
early endosomes, where NOD1 and RIP2 are recruited (Irving
et al., 2014). Regarding microbiota-derived OMVs, confocal
fluorescence microscopy analysis performed at 60 min post-
stimulation confirmed that OMVs from both EcN and ECOR12
colocalize with the endosome marker EEA1 and with NOD1.
At this incubation time, NOD1 was found associated with
early endosomes only in OMVs-treated cells. The overlap
coefficients calculated for the colocalization of OMVs with
EEA1 match those reported previously at 30 min (Cañas
et al., 2016), and are compatible with the transient location of
OMVs in early endosomes during their trafficking to lysosomes.
Similar overlapping coefficient values were obtained here for
EEA1/NOD1 signals, which is consistent with the fact that NOD1
associates to early endosomes to interact with PG contained in
OMVs.
It is known that NOD receptors recognize muramyl peptides
derived from bacterial PG. These active degradation products
can be generated by the action of amidases or lytic enzymes
either of bacterial (muramidases) or from mammalian origin
(lysozyme type enzymes) (Girardin et al., 2003). The study
carried out with H. pylori OMVs did not reveal how NOD1-
activating peptides are generated from PG-OMVs and how they
are presented to NOD1 (Irving et al., 2014). In this sense, both
endosomal enzymes and the acidic pH of endosomes (pH 5.5–
6) seem to be essential for the processing of NOD1-activating
peptides derived from bacterial PG (Lee et al., 2009). In addition,
bacterial OMVs contain PG hydrolytic enzymes that can account
for the release of muramyl peptides (reviewed in Jan, 2017).
Enzymatic generation of these peptides into the endosomal
compartment, together with the presence of a transport system
for oligopeptides in the endosome membrane (SLC15A4), which
acts as a gateway for the release of these active peptides to the
cytosol (Lee et al., 2009), may help NOD1 interaction and its
activation to initiate the phosphorylation cascade that leads to
activation of NF-κB.
Clearly, the formation and processing of NOD1-activating
muramyl peptides from internalized OMVs require bacterial
and/or endosomal enzymes. Thus, differences in the OMVs
cargo or in the envelope vesicular structure may influence
the availability of active muramyl peptides. As stated above,
vesicles from the probiotic EcN and the commensal ECOR12
elicited similar IL-6 and IL-8 responses, although they differed
in their initial kinetics of NOD1 and NF-κB activation. We
may speculate that these differences could be attributed to
different vesicular cargo, especially in the content of PG-
degrading enzymes. OMVs from the probiotic EcN contain
several lytic murein transglycosylases such as MtlA, MtlB
and EmtA (Aguilera et al., 2014), but no information is
available so far on the ECOR12 OMV- proteome. Other factors
related with the vesicular envelope may also contribute to
the different activating profile. For example, the probiotic
EcN contains a K5 polysaccharide capsule that is absent
in the commensal ECOR12. The presence of this capsule
on the surface of EcN OMVs may influence the action of
PG processing enzymes. The faster the active PG-derived
peptides are produced the less time is needed for NOD1
activation.
CONCLUSION
Modulation of the innate immune system by gut microbiota has
essential role in maintaining gut homeostasis, both helping quick
responses against pathogens and preserving hyporesponsiveness
to commensal bacteria and innocuous antigens. In this study,
we provide evidence that OMVs released by beneficial gut
bacteria provide a mechanism for PG delivery into the host
cytosol, thus allowing the sensing of microbial products
that steadily prime the innate immune system. The constant
stimulation of NOD1 by microbiota vesicles results in controlled
inflammatory responses that may help pathogen eradication
and host survival. Therefore, by this mechanism microbiota
OMVs contribute to immune responses essential to maintaining
intestinal homeostasis.
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